Search Results
Found 43 results for "clinical trials" across articles, medicines, trials, companies and the glossary
Industry
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
A comprehensive guide to utilizing Priya Life Science's live trackers. Learn how to track clinical trials, regulatory recalls, drug shortages, biotech layoffs, and M&A venture activity to accelerate your career and optimize market intelligence.
Industry
GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons
An in-depth clinical and market analysis of GLP-1 therapeutics in 2026, examining central brain reward circuit mapping from the University of Virginia, Phase 3 oral small-molecule data for Orforglipron, Retatrutide triple-agonist efficacy, and systemic cardiometabolic benefits.
Industry
Women in Pharma Awards 2026 Recognise Sector’s Outstanding Talent Across Ireland
20 trophies presented at gala Dublin ceremony celebrating leadership, innovation, and clinical trials excellence across Ireland's €100B+ pharmaceutical and life sciences sector.
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
Industry
UK Pharma CV Guide 2026: MHRA Standards, Golden Triangle Hubs & Free ATS CV Builder
Complete 2026 guide to writing an ATS-compliant pharmaceutical CV in the UK. Features MHRA & ABPI standards, UK 2-page CV conventions, Golden Triangle recruitment benchmarks, and free ATS CV Studio tools.
Biotechnology
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.
Industry
The €8.5 Billion Defense: Dutch Innovative Pharma Fights Back Against Cost-Control Policies
The Dutch Association for Innovative Medicines (VIG) releases a detailed report highlighting the sector\'s €8.5 billion gross added value, warning that cost-containment measures threaten patient access, clinical trials, and Europe\'s biopharma sovereignty.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Regulatory Affairs
The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories
An in-depth commercial analysis of the UK-India Comprehensive Economic and Trade Agreement (CETA), exploring its transformative impact on bilateral pharmaceutical manufacturing, active pharmaceutical ingredient (API) supply chains, and consumer medicine pricing.
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
Regulatory Affairs
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
Industry
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
The University of Galway has been chosen to lead the new €64.5 million Research Ireland Rinn Medical Devices Centre as part of a landmark €460 million government investment in seven new national Rinn research centres.
MedTech
Cork MedTech Innovator NeuroBell Secures $5.5M to Accelerate Launch of AI Neonatal Seizure Monitor Luna
NeuroBell, a spin-out from University College UCC, has closed a $5.5 million (€4.8 million) funding round led by Elkstone to secure US regulatory clearance and commercialize its AI-powered neonatal seizure detection device, Luna.
Regulatory Affairs
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
In a landmark world-first, Irish-founded Chanelle McCoy Health has received official regulatory approvals from the Saudi Food and Drug Authority and confirmation of safety under EU Novel Food guidelines for its Pureis® Ultra Pure CBD range.
Regulatory Affairs
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
An explanation of the 5 modules of the ICH Common Technical Document (CTD) format required for global drug marketing authorization applications.
Regulatory Affairs
Therapeutic Hotspots of 2026: Evolving Pipelines in Antibody-Drug Conjugates (ADCs) and GLP-1 Obesity Platforms
Global research pipelines and venture capital inflows are concentrating in targeted cancer therapy with ADCs and next-generation cardiometabolic GLP-1 oral weight-loss compounds.
Pharmaceutical
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
An exhaustive guide detailing postgraduate Level 9 pharmaceutical master's programs across Irish universities, covering tuition fees, eligibility criteria, and requirements for international applicants.
MedTech
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
Artificial intelligence has evolved from sandbox pilot projects to become the default operating system driving drug discovery, clinical trials, and sterile manufacturing.
Industry
MedTech Pioneer CroíValve Closes $27 Million Series B Expansion to Advance Transcatheter Tricuspid Heart Valve Treatment
Dublin-based medical device developer CroíValve has secured a $27 million expansion of its Series B round, combining equity funding led by BGF and state grants to accelerate US and EU clinical trials for its DUO Adapt System.
Biotechnology
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
Regulatory Affairs
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.
Regulatory Affairs
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.
Clinical Trials
Helus Pharma Secures US$50M Offering as MDD Trial Surpasses 86% Enrollment
Helus Pharma announces a $50 million offering to progress Phase 3 trials for their novel serotonergic agonists, alongside major clinical milestones and leadership updates.
Industry
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Around 90 women with advanced cervical cancer in the UK could be eligible for treatment with Regeneron's immunotherapy Libtayo each year, following a green light from NICE.
Biotechnology
A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge
An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.
Pharmaceutical
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
Regulatory Affairs
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.
Industry
AbbVie Nears $11 Billion Acquisition of Apogee Therapeutics to Bolster Immunology Pipeline
AbbVie is reportedly in advanced negotiations to acquire clinical-stage biotech Apogee Therapeutics for approximately $10.9 billion in cash, aiming to secure the promising long-acting eczema therapy zumilokibart.
Biotechnology
Council Agrees Mandate on Measures to Advance Biotech Innovation in the EU
The Council has agreed its position on targeted amendments to health legislation that seek to boost innovation in the EU's biotechnology sector, updating rules on genetically modified micro-organisms and organ processing.
Biotechnology
The European Biotech Act 2026: A Catalyst for Competitiveness and Innovation in Health Biotechnology
The European Commission has proposed the European Biotech Act to turbocharge the EU's health biotechnology sector, streamline regulations, and regain global competitiveness against the US and China.
Pharmaceutical
Avectas: Engineering the Future of Cell Therapy Manufacturing
Recognizing the critical industry bottleneck in scalable cell therapy production, Avectas has announced a landmark collaboration with CCRM and OmniaBio to evaluate its innovative manufacturing platform.
LinkedIn
How to Create a LinkedIn Profile Using AI: The 2026 Guide for Life Science Professionals
Step-by-step guide to building a standout LinkedIn profile using ChatGPT and AI tools - written for pharma, biotech, and MedTech professionals in Ireland. Includes copy-paste AI prompts for every section.
Biotechnology
Rare Disease Bottlenecks vs. Encouraging Clinical Trial Growth in Ireland
Despite encouraging growth in clinical trial activity, patients in Ireland face an average wait of 801 days for access to rare disease medicines, prompting calls for urgent systemic reform.
MedTech
EU-India FTA: A New Era of Trade Creating a 2 Billion People Free Trade Zone
Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.
MedTech
Emerging Pharma Companies in Ireland to Watch in 2026
Discover the top 5 high-growth Irish life science, biotech, and medtech companies transforming the healthcare landscape. From Enterprise Ireland backed startups to global scale-ups, these are the emerging leaders of 2026.
MedTech
From Generative to Agentic: How Multi-Agent AI Workflows Are Automating Clinical Trials in Ireland
An in-depth analysis of the shift from passive generative AI to active agentic AI in clinical research. We explore how Irish clinical trial teams use multi-agent workflows to automate administrative burdens, GxP validation via local frameworks like Ollama, and how Priya LifePDF ensures document privacy.
Pharmaceutical
From Powerhouse to Pioneer: How Ireland's Life Science Sector Is Pivoting from Manufacturing to an R&D-Led Innovation Hub in 2026
An in-depth analysis of Ireland's National Life Science Innovation Strategy in 2026. We examine the structural challenges of this transition-including specialised R&D infrastructure, the acute talent shortage in cell and gene therapies (CGT), and how digital compliance tools like Priya LifePDF streamline the transition.
MedTech
The Digital-First Regulatory Landscape: How Ireland's Life Science Sector Is Adapting to the EU AI Act, EHDS, and Governance by Design
A comprehensive guide for Irish pharmaceutical, MedTech, and life science professionals on the EU AI Act implementation, the European Health Data Space, cGMP compliance in an AI-driven environment, ALCOA+ in digital systems, and the practical steps organisations must take to achieve governance by design in 2026.